妊娠合并心血管病抗凝治疗概况  

Survey on anticoagulant therapy in pregnant women with cardiovascular disease

作　　者：熊琴梅[1] 洪葵[1] 

机构地区：[1]南昌大学第二附属医院心内科

出　　处：《中国临床药理学与治疗学》2014年第2期223-227,共5页Chinese Journal of Clinical Pharmacology and Therapeutics

摘　　要：近年来,抗凝治疗药物的广泛应用使得越来越多的患者从防治血栓栓塞事件中获益。然而,抗凝药物好比一把双刃剑,常常是风险与受益并存。如何平衡防治栓塞和出血的矛盾并优化治疗方案,始终是临床医生必须面对的一个严峻问题。除此之外,妊娠期妇女这类特殊人群的抗凝药物使用更是一个复杂且充满挑战的难题。基于近年来妊娠妇女抗凝药物治疗的临床研究,以及最新相关指南的推荐,本综述从妊娠妇女的高凝状态、主要抗凝药物种类及临床应用几方面介绍妊娠合并心血管病患者的抗凝治疗概况。In recent years, extensive applica tion of anticoagulation drugs benefits more and more patients suffering from thromboembolic e vents. However, the anticoagulants have bene fits and risks, which like a double-edged sword. How to balance the prevention of thromboembo lism and the bleeding problems and optimize the treatments might be a serious problem for clini cal physicians. Considering the women with pregnancy, anticoagulant therapy is a complex and challenging problem. According to the latestguidelines and recent studies on pregnant women with anticoagulant therapy, this review summa rized anticoagulant therapies for the pregnant women with cardiovascular diseases, which in cludes the hypercoagulable states of pregnant women, the main types of anticoagulant drugs and clinical application.

关 键 词：妊娠 心血管病 抗凝 华法林 肝素 

分 类 号：R543[医药卫生—心血管疾病]